Detalhe da pesquisa
1.
An Update on the Current and Emerging Use of Thiazolidinediones for Type 2 Diabetes.
Medicina (Kaunas)
; 58(10)2022 Oct 17.
Artigo
Inglês
| MEDLINE | ID: mdl-36295635
2.
Experimental and Emerging Free Fatty Acid Receptor Agonists for the Treatment of Type 2 Diabetes.
Medicina (Kaunas)
; 58(1)2022 Jan 11.
Artigo
Inglês
| MEDLINE | ID: mdl-35056417
3.
Novel Therapeutical Approaches to Managing Atherosclerotic Risk.
Int J Mol Sci
; 22(9)2021 Apr 28.
Artigo
Inglês
| MEDLINE | ID: mdl-33924893
4.
GLP-1 receptor agonists and reduction of cardiometabolic risk: Potential underlying mechanisms.
Biochim Biophys Acta Mol Basis Dis
; 1864(9 Pt B): 2814-2821, 2018 09.
Artigo
Inglês
| MEDLINE | ID: mdl-29778663
5.
Liraglutide improves metabolic parameters and carotid intima-media thickness in diabetic patients with the metabolic syndrome: an 18-month prospective study.
Cardiovasc Diabetol
; 15(1): 162, 2016 Dec 03.
Artigo
Inglês
| MEDLINE | ID: mdl-27912784
6.
Liraglutide decreases carotid intima-media thickness in patients with type 2 diabetes: 8-month prospective pilot study.
Cardiovasc Diabetol
; 13: 49, 2014 Feb 22.
Artigo
Inglês
| MEDLINE | ID: mdl-24559258
7.
Metabolic dysfunction-associated fatty liver disease: current therapeutic strategies.
Front Nutr
; 11: 1355732, 2024.
Artigo
Inglês
| MEDLINE | ID: mdl-38567250
8.
Effect of Semaglutide on Subclinical Atherosclerosis and Cardiometabolic Compensation: A Real-World Study in Patients with Type 2 Diabetes.
Biomedicines
; 11(5)2023 May 04.
Artigo
Inglês
| MEDLINE | ID: mdl-37239033
9.
Treatment with Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors (PCSK9i): Current Evidence for Expanding the Paradigm?
J Cardiovasc Pharmacol Ther
; 28: 10742484231186855, 2023.
Artigo
Inglês
| MEDLINE | ID: mdl-37448204
10.
Advances in the Pharmacological Management of Diabetic Nephropathy: A 2022 International Update.
Biomedicines
; 11(2)2023 Jan 20.
Artigo
Inglês
| MEDLINE | ID: mdl-36830828
11.
Relationship among Body Composition, Adipocytokines, and Irisin on Exercise Capacity and Quality of Life in COPD: A Pilot Study.
Biomolecules
; 13(1)2022 12 27.
Artigo
Inglês
| MEDLINE | ID: mdl-36671433
12.
Novel molecular markers of cardiovascular disease risk in type 2 diabetes mellitus.
Biochim Biophys Acta Mol Basis Dis
; 1867(8): 166148, 2021 08 01.
Artigo
Inglês
| MEDLINE | ID: mdl-33892081
13.
Liraglutide Reduces Carotid Intima-Media Thickness by Reducing Small Dense Low-Density Lipoproteins in a Real-World Setting of Patients with Type 2 Diabetes: A Novel Anti-Atherogenic Effect.
Diabetes Ther
; 12(1): 261-274, 2021 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-33210276
14.
Leptin and TGF-ß1 Downregulate PREP1 Expression in Human Adipose-Derived Mesenchymal Stem Cells and Mature Adipocytes.
Front Cell Dev Biol
; 9: 700481, 2021.
Artigo
Inglês
| MEDLINE | ID: mdl-34327205
15.
The efficacy and safety of dipeptidyl peptidase-4 inhibitors compared to other oral glucose-lowering medications in the treatment of type 2 diabetes.
Metabolism
; 109: 154295, 2020 08.
Artigo
Inglês
| MEDLINE | ID: mdl-32553739
16.
Impact of Glucose-Lowering Medications on Cardiovascular and Metabolic Risk in Type 2 Diabetes.
J Clin Med
; 9(4)2020 Mar 26.
Artigo
Inglês
| MEDLINE | ID: mdl-32225082
17.
Liraglutide Increases Serum Levels of MicroRNA-27b, -130a and -210 in Patients with Type 2 Diabetes Mellitus: A Novel Epigenetic Effect.
Metabolites
; 10(10)2020 Sep 30.
Artigo
Inglês
| MEDLINE | ID: mdl-33008044
18.
Pasta Supplemented with Opuntia ficus-indica Extract Improves Metabolic Parameters and Reduces Atherogenic Small Dense Low-Density Lipoproteins in Patients with Risk Factors for the Metabolic Syndrome: A Four-Week Intervention Study.
Metabolites
; 10(11)2020 Oct 26.
Artigo
Inglês
| MEDLINE | ID: mdl-33114614
19.
Advances in pharmacological treatment of type 1 diabetes during pregnancy.
Expert Opin Pharmacother
; 20(8): 983-989, 2019 06.
Artigo
Inglês
| MEDLINE | ID: mdl-30924387
20.
Future perspectives of the pharmacological management of diabetic dyslipidemia.
Expert Rev Clin Pharmacol
; 12(2): 129-143, 2019 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-30644763